Cargando…
Erdheim-Chester Disease: a comprehensive review of the literature
Erdheim-Chester Disease (ECD) is a rare form of non Langerhans' cell histiocytosis. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. Males and females are almost equally affected. The multi systemic form of ECD is associated with significant m...
Autores principales: | Mazor, Roei D, Manevich-Mazor, Mirra, Shoenfeld, Yehuda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849848/ https://www.ncbi.nlm.nih.gov/pubmed/24011030 http://dx.doi.org/10.1186/1750-1172-8-137 |
Ejemplares similares
-
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series
por: Mazor, Roei D, et al.
Publicado: (2014) -
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease
por: Weissman, Ran, et al.
Publicado: (2020) -
PB2208: CLUSTER ANALYSIS UNVEILS THE CLINICAL SPECTRUM OF ERDHEIM-CHESTER DISEASE
por: Tesi, Michelangelo, et al.
Publicado: (2023) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy
por: Mazor, Roei D, et al.
Publicado: (2020)